Literature DB >> 15075225

Cellular mechanisms of direct-current electric field effects: galvanotaxis and metastatic disease.

Maria E Mycielska1, Mustafa B A Djamgoz.   

Abstract

Endogenous direct-current electric fields (dcEFs) occur in vivo in the form of epithelial transcellular potentials or neuronal field potentials, and a variety of cells respond to dcEFs in vitro by directional movement. This is termed galvanotaxis. The passive influx of Ca(2+) on the anodal side should increase the local intracellular Ca(2+) concentration, whereas passive efflux and/or intracellular redistribution decrease the local intracellular Ca(2+) concentration on the cathodal side. These changes could give rise to 'push-pull' effects, causing net movement of cells towards the cathode. However, such effects would be complicated in cells that possess voltage-gated Ca(2+) channels and/or intracellular Ca(2+) stores. Moreover, voltage-gated Na(+) channels, protein kinases, growth factors, surface charge and electrophoresis of proteins have been found to be involved in galvanotaxis. Galvanotactic mechanisms might operate in both the short term (seconds to minutes) and the long term (minutes to hours), and recent work has shown that they might be involved in metastatic disease. The galvanotactic responses of strongly metastatic prostate and breast cancer cells are much more prominent, and the cells move in the opposite direction compared with corresponding weakly metastatic cells. This could have important implications for the metastatic process and has clinical implications. Galvanotaxis could thus play a significant role in both cellular physiology and pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15075225     DOI: 10.1242/jcs.01125

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  83 in total

1.  A chemical genetics approach reveals H,K-ATPase-mediated membrane voltage is required for planarian head regeneration.

Authors:  Wendy S Beane; Junji Morokuma; Dany S Adams; Michael Levin
Journal:  Chem Biol       Date:  2011-01-28

2.  Small-cell lung cancer (human): potentiation of endocytic membrane activity by voltage-gated Na(+) channel expression in vitro.

Authors:  P U Onganer; M B A Djamgoz
Journal:  J Membr Biol       Date:  2005-03       Impact factor: 1.843

Review 3.  Bioelectric mechanisms in regeneration: Unique aspects and future perspectives.

Authors:  Michael Levin
Journal:  Semin Cell Dev Biol       Date:  2009-05-03       Impact factor: 7.727

4.  Regulation of cell cytoskeleton and membrane mechanics by electric field: role of linker proteins.

Authors:  Igor Titushkin; Michael Cho
Journal:  Biophys J       Date:  2009-01       Impact factor: 4.033

Review 5.  In vitro and in vivo neuronal electrotaxis: a potential mechanism for restoration?

Authors:  Ali Jahanshahi; Lisa-Maria Schönfeld; Evi Lemmens; Sven Hendrix; Yasin Temel
Journal:  Mol Neurobiol       Date:  2013-11-16       Impact factor: 5.590

Review 6.  Role of membrane potential in the regulation of cell proliferation and differentiation.

Authors:  Sarah Sundelacruz; Michael Levin; David L Kaplan
Journal:  Stem Cell Rev Rep       Date:  2009-06-27       Impact factor: 5.739

Review 7.  [Value of galvanotherapy for localised prostate cancer].

Authors:  C Arsov; C Winter; P Albers
Journal:  Urologe A       Date:  2009-07       Impact factor: 0.639

8.  Different roles of membrane potentials in electrotaxis and chemotaxis of dictyostelium cells.

Authors:  Run-Chi Gao; Xiao-Dong Zhang; Yao-Hui Sun; Yoichiro Kamimura; Alex Mogilner; Peter N Devreotes; Min Zhao
Journal:  Eukaryot Cell       Date:  2011-07-08

9.  Bioelectric Control of Metastasis in Solid Tumors.

Authors:  Samantha L Payne; Michael Levin; Madeleine J Oudin
Journal:  Bioelectricity       Date:  2019-09-16

10.  Electroceutical Management of Bacterial Biofilms and Surgical Infection.

Authors:  Chandan K Sen; Shomita S Mathew-Steiner; Amitava Das; Vishnu Baba Sundaresan; Sashwati Roy
Journal:  Antioxid Redox Signal       Date:  2020-07-10       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.